Galantamine IR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Galantamine IR, covering 2011-05-19 to 2011-05-19. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease [Phase 3]